Closure Device-Related Thrombosis After Anticoagulation With Dabigatran in Patients Undergoing Percutaneous Left

Xiaoye Li1, Qinchun Jin2, Xiaochun Zhang2

  • 1Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.

Insights

Left atrial appendage closure (LAAC) prevents stroke in atrial fibrillation (AF) patients. Rare device-related thrombosis (DRT) occurred with dabigatran but resolved after switching to rivaroxaban or warfarin.

Area of Science:

  • Cardiology
  • Medical Devices
  • Thrombosis

Background:

  • Percutaneous left atrial appendage closure (LAAC) is a stroke prevention strategy for atrial fibrillation (AF) patients intolerant to long-term anticoagulation.
  • LAAC devices aim to reduce thromboembolic events in high-risk AF populations.

Observation:

  • Four rare cases of device-related thrombosis (DRT) were observed after successful LAAC procedures.
  • Patients received dabigatran anticoagulation post-procedure, and DRT was diagnosed via transesophageal echocardiogram (TEE) during follow-up.

Findings:

  • Thrombosis formed on the LAAC occluder device despite dabigatran therapy.
  • Switching anticoagulation from dabigatran to rivaroxaban or warfarin led to thrombosis regression within one month.

Implications:

  • These findings highlight a potential complication of LAAC with specific anticoagulants.
  • Alternative anticoagulation strategies may be necessary for managing DRT after LAAC.
  • Further research is warranted to optimize anticoagulation protocols post-LAAC to prevent DRT.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
170
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
143